The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.

Puerarin (PUE) is a good candidate for treating stroke, but its low concentration in brain after administration limits its curative efficacy. The aim of the present work was to design and characterize PUE loaded poly(butylcyanoacrylate) nanoparticles (PBCN) coated with polysorbate 80 (Ps 80), and to evaluate the effect of PBCN on the permeability of PUE across the blood-brain barrier (BBB) and the effect of PUE loaded PBCN on the cerebral ischemia/reperfusion injury. PUE loaded PBCN were successfully prepared by anionic polymerization method with the mean particle size of 201.2 nm and the zeta potential of -7.72 mV. The in vitro release behavior of PUE from the nanoparticles showed a biphasic profile manner with an initial burst release followed by a sustained release. The results of pharmacokinetic and biodistribution to brain performed in mice after intravenous administration showed that the drug concentrations in blood and brain for PUE loaded PBCN were both greater than these for the free drug. Moreover, compared with free drug, the vein injection of PUE loaded PBCN exerted the better neuroprotective effect in rats with focal cerebral ischemic injury via significantly decreasing neurological deficit scores, increasing body weight, lowing brain water content, and reducing the infarct volume. The results indicated that this preparation may reduce the total dose required for the stroke therapy with concurrent reduction in dose related toxicity. All these findings suggest that PBCN could enhance the transport of PUE to brain and have a potential as a neuroprotective agent in the focal cerebral ischemic injury.

[1]  Peter Ramge,et al.  Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.

[2]  D. Hess,et al.  Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats , 2004, BMC neurology.

[3]  J. Sheu,et al.  Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats , 2009, Journal of Biomedical Science.

[4]  A. Chan,et al.  Pharmacokinetic, Tissue Distribution, and Excretion of Puerarin and Puerarin-Phospholipid Complex in Rats , 2006, Drug development and industrial pharmacy.

[5]  S. B. Nair,et al.  Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke. , 2012, Current medicinal chemistry.

[6]  S. Feng,et al.  Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Yaodong Jiang,et al.  Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer , 2011, Pharmaceutical Research.

[8]  G. Zhai,et al.  Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle , 2010 .

[9]  J. Kreuter,et al.  Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) , 1995, Brain Research.

[10]  Wei Wang,et al.  Determination of puerarin in rat cortex by high-performance liquid chromatography after intravenous administration of Puerariae flavonoids. , 2006, Biomedical chromatography : BMC.

[11]  Xiaoxiang Zheng,et al.  The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats. , 2005, Planta medica.

[12]  S. Barnes,et al.  Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. , 2004, Journal of agricultural and food chemistry.

[13]  Liang Jiang,et al.  Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model , 2009, Brain Research.

[14]  S. Leung,et al.  Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. , 2006, European journal of pharmacology.

[15]  G. Wang,et al.  Implication of the c-Jun-NH2-terminal kinase pathway in the neuroprotective effect of puerarin against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells , 2011, Neuroscience Letters.

[16]  K. Kimura,et al.  Stroke incidence and usage rate of thrombolysis in a Japanese urban city: the Kurashiki stroke registry. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[17]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[18]  Tatsuo Yamamoto,et al.  Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. , 2004, Planta medica.

[19]  R. Murthy,et al.  Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles. , 2004, Acta pharmaceutica.

[20]  M. Samanta,et al.  Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  A. Feher,et al.  Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases. , 2011, International journal of cardiology.

[22]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[23]  P. Couvreur,et al.  Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? , 2005, International journal of pharmaceutics.

[24]  D D Allen,et al.  Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.

[25]  Xinguo Jiang,et al.  Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. , 2006, International journal of pharmaceutics.

[26]  M. Samanta,et al.  Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease , 2008, Brain Research.

[27]  J. Kreuter,et al.  Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles , 1999, Pharmaceutical Research.

[28]  R. Borchardt,et al.  The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System , 1996, Pharmaceutical Research.

[29]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.

[30]  J. Woo,et al.  Stroke subtypes among Chinese living in Hong Kong , 1992, Neurology.

[31]  Gao Li,et al.  Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemia-reperfusion injury. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[32]  G. Zhai,et al.  Evaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticles , 2012, Journal of Nanoparticle Research.

[33]  R. Murthy,et al.  Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier , 2011, Pharmaceutical Research.

[34]  K. Landfester,et al.  The First Step into the Brain: Uptake of NIO‐PBCA Nanoparticles by Endothelial Cells in vitro and in vivo, and Direct Evidence for their Blood–Brain Barrier Permeation , 2008, ChemMedChem.

[35]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[36]  E. Kılıç,et al.  Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia , 2006, Nature Neuroscience.

[37]  D. Begley,et al.  Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells , 2000, The European journal of neuroscience.

[38]  G. Du,et al.  Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. , 2007, Pharmacological research.

[39]  R. Löbenberg,et al.  Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.

[40]  D. C. Rogers,et al.  Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. , 1997, Stroke.

[41]  Hui-jie Zhang,et al.  Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. , 2010, European journal of pharmacology.

[42]  Yi Ding,et al.  HPLC method for the determination and pharmacokinetic studies on puerarin in cerebral ischemia reperfusion rat plasma after intravenous administration of puerariae radix isoflavone. , 2005, Journal of pharmaceutical and biomedical analysis.

[43]  K. Hosoya,et al.  The blood-brain barrier efflux transporters as a detoxifying system for the brain. , 1999, Advanced drug delivery reviews.

[44]  G. Zhai,et al.  Enhancement of oral bioavailability of puerarin by polybutylcyanoacrylate nanoparticles , 2011 .

[45]  M. Rafiee-Tehrani,et al.  Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[46]  J. Kreuter,et al.  Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants , 1990 .

[47]  A. Lowman,et al.  Biodegradable nanoparticles for drug delivery and targeting , 2002 .

[48]  Feng Yan,et al.  Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia , 2009, Neurological research.